Dutch renewables company Avantium has appointed Bart Welten as chief financial officer (CFO), effective January 2020.

Welten has 30 years of experience in finance and extensive knowledge of the chemical and life-sciences industries. Prior to joining Avantium he was CFO of Centrient Pharmaceuticals, the former joint venture of DSM and Sinochem in Singapore. Welten also served as CFO of DSM Resins and DSM Anti-Infectives. He holds a law degree from Leiden University, Netherlands and an MBA from Boston College, USA.

Tom van Aken, CEO of Avantium said: “We are delighted to welcome Bart to Avantium as our new CFO. He brings a wealth of international finance and managerial experience, and we are confident that he will make a very important contribution to Avantium and help enable us to deliver our strategic objectives.”